Found 9 matching trials
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
PHASE3This is an international, multicenter, randomized, double-blind, placebo-co...
Location
Arizona Pulmonary Specialists, Ltd.
Telemonitoring to Treat Group 2 Pulmonary Hypertension
PHASE2This study aims to decrease elevated pressure in the lungs of patients with...
Location
George Washington University
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
PHASE3This study provided/continued to provide oral treprostinil (UT-15C SR; trep...
Location
The Kirklin Clinic
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
PHASE3This study is an international, multi-center, open-label study designed to ...
Location
Arizona Pulmonary Specialists, Ltd.
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
PHASE3This was an open-label study to evaluate the safety of continued therapy wi...
Location
University of Alabama at Birmingham
Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension
PHASE3This study is an international, multi-center, randomized, double-blind, pla...
Location
University of Alabama-Birmingham
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
N/AThis prospective, observational, multicenter, patient registry will follow ...
Status
Active Not Recruiting
Location
University of California - San Francisco
Three Times Daily Dosing of UT-15C
PHASE1To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in h...
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
PHASE3This was a multicenter, randomized (1:1; oral treprostinil to placebo), dou...
Location
University of Alabama at Birmingham